January is designated as “Cervical Cancer Awareness Month”, with various global activities that highlight and increase awareness of cervical cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of cervical cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide the useful information for this field. The list of relevant papers can be seen below.

“Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota—Evidence from Next-Generation Sequencing Studies”
by Maria Głowienka-Stodolak, Katarzyna Bagińska-Drabiuk, Sebastian Szubert, Ewa E. Hennig, Agnieszka Horala, Michalina Dąbrowska, Martyna Micek, Michał Ciebiera and Natalia Zeber-Lubecka
Cancers 2024, 16(2), 399; https://doi.org/10.3390/cancers16020399
Available online: https://www.mdpi.com/2072-6694/16/2/399  

“Why Is Surgery Still Done after Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer in Romania?”
by Silviu Cristian Voinea, Cristian Ioan Bordea, Elena Chitoran, Vlad Rotaru, Razvan Ioan Andrei, Sinziana-Octavia Ionescu, Dan Luca, Nicolae Mircea Savu, Cristina Mirela Capsa, Mihnea Alecu et al.
Cancers 2024, 16(2), 425; https://doi.org/10.3390/cancers16020425
Available online: https://www.mdpi.com/2072-6694/16/2/425

“Recent Therapeutic Advances in Gynecologic Oncology: A Review”
by Elise M. Wilson, Ramez N. Eskander and Pratibha S. Binder
Cancers 2024, 16(4), 770; https://doi.org/10.3390/cancers16040770
Available online: https://www.mdpi.com/2072-6694/16/4/770

“The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023)”
by Daniela Fischerova, Filip Frühauf, Andrea Burgetova, Ingfrid S. Haldorsen, Elena Gatti and David Cibula
Cancers 2024, 16(4), 775; https://doi.org/10.3390/cancers16040775
Available online: https://www.mdpi.com/2072-6694/16/4/775

“Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies”
by Jennifer Le Guévelou, Lise Selleret, Enora Laas, Fabrice Lecuru and Manon Kissel
Cancers 2024, 16(7), 1341; https://doi.org/10.3390/cancers16071341
Available online: https://www.mdpi.com/2072-6694/16/7/1341

“Gynecologic Oncology Group Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO)”
by Stefano Restaino, Giulia Pellecchia, Martina Arcieri, Giorgio Bogani, Cristina Taliento, Pantaleo Greco, Lorenza Driul, Vito Chiantera, Alfredo Ercoli, Francesco Fanfani et al.
Cancers 2024, 16(14), 2541; https://doi.org/10.3390/cancers16142541
Available online: https://www.mdpi.com/2072-6694/16/14/2541

“Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy—An Updated Meta-Analysis”
by Carlo Ronsini, Maria Cristina Solazzo, Eleonora Braca, Giada Andreoli, Maria Giovanna Vastarella, Stefano Cianci, Vito Andrea Capozzi, Marco Torella, Luigi Cobellis and Pasquale De Franciscis
Cancers 2024, 16(14), 2542; https://doi.org/10.3390/cancers16142542
Available online: https://www.mdpi.com/2072-6694/16/14/2542

“Predictors of Clinical Hematological Toxicities under Radiotherapy in Patients with Cervical Cancer—A Risk Analysis”
by Serban Andrei Marinescu, Radu-Valeriu Toma, Oana Gabriela Trifănescu, Laurentia Nicoleta Gales, Antonia Ruxandra Folea, Adrian Sima, Liviu Bîlteanu and Rodica Anghel
Cancers 2024, 16(17), 3032; https://doi.org/10.3390/cancers16173032
Available online: https://www.mdpi.com/2072-6694/16/17/3032

“Exploring Factors Influencing Cervical Cancer Screening Participation among Singaporean Women: A Social Ecological Approach”
by Qing Huang and Li-Ying Tan
Cancers 2024, 16(20), 3475; https://doi.org/10.3390/cancers16203475
Available online: https://www.mdpi.com/2072-6694/16/20/3475

“Retrospective Evaluation of GEC-ESTRO Constraints for Definitive Radiochemotherapy with Brachytherapy and Correlation with Oncologic Outcome in Cervical Cancer: A Monocenter Study”
by Tom Schönicke, Raphael Koch, Isabel Vogt, Isabel Falke, Hans Theodor Eich and Gabriele Reinartz
Cancers 2024, 16(20), 3495; https://doi.org/10.3390/cancers16203495
Available online: https://www.mdpi.com/2072-6694/16/20/3495

“ZNF281 Facilitates the Invasion of Cervical Cancer Cell Both In Vivo and In Vitro”
by Ye Chong, Kun Zhang, Yuting Zeng, Qian Chen, Qian Feng, Nan Cui, Pengsheng Zheng, Litao Ruan and Wei Hua
Cancers 2024, 16(21), 3717; https://doi.org/10.3390/cancers16213717  
Available online: https://www.mdpi.com/2072-6694/16/21/3717

“Agreement Between High-Risk Human Papillomavirus Testing in Paired Self-Collected and Clinician-Collected Samples from Cervical Cancer Screening in Spain”
by Raquel Ibáñez, Esther Roura, Francisca Morey, Miguel Andújar, Miquel Ángel Pavón, Amelia Acera, Laia Bruni and Silvia de Sanjosé
Cancers 2025, 17(1), 63; https://doi.org/10.3390/cancers17010063 
Available online: https://doi.org/10.3390/cancers17010063  

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office.